本页面由Tiger Trade Technology Pte. Ltd.提供服务

Aclaris Therapeutics

3.60
-0.2300-6.01%
盘前:3.940.3400+9.44%06:19 EDT
成交量:342.90万
成交额:1,250.52万
市值:5.30亿
市盈率:-6.14
高:3.84
开:3.80
低:3.59
收:3.83
52周最高:6.60
52周最低:1.74
股本:1.47亿
流通股本:1.01亿
量比:0.51
换手率:3.40%
股息:- -
股息率:- -
每股收益(TTM):-0.5861
每股收益(LYR):-0.5300
净资产收益率:-59.10%
总资产收益率:-28.98%
市净率:4.25
市盈率(LYR):-6.79

数据加载中...

2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

重要事件披露

Form 8-K - Current report
2024/02/05

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/02/01

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/19

重要事件披露

Form 8-K - Current report
2024/01/16

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/20

重要事件披露

Form 8-K - Current report
2023/12/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/11

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/25

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/13

重要事件披露

Form 8-K - Current report
2023/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/06

重要事件披露

Form 8-K - Current report
2023/10/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/18

重要事件披露

Form 8-K - Current report
2023/09/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]